DE2725666A1 - Verfahren zur herstellung eines injizierbaren waessrigen kolloids aus technetium-99m-calciumphytat - Google Patents

Verfahren zur herstellung eines injizierbaren waessrigen kolloids aus technetium-99m-calciumphytat

Info

Publication number
DE2725666A1
DE2725666A1 DE19772725666 DE2725666A DE2725666A1 DE 2725666 A1 DE2725666 A1 DE 2725666A1 DE 19772725666 DE19772725666 DE 19772725666 DE 2725666 A DE2725666 A DE 2725666A DE 2725666 A1 DE2725666 A1 DE 2725666A1
Authority
DE
Germany
Prior art keywords
solution
phytate
chloride
calcium
calcium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772725666
Other languages
German (de)
English (en)
Inventor
Jacques Andre Nadeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2725666A1 publication Critical patent/DE2725666A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19772725666 1976-06-07 1977-06-06 Verfahren zur herstellung eines injizierbaren waessrigen kolloids aus technetium-99m-calciumphytat Ceased DE2725666A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA254,190A CA1053149A (en) 1976-06-07 1976-06-07 Diagnostic kit

Publications (1)

Publication Number Publication Date
DE2725666A1 true DE2725666A1 (de) 1977-12-15

Family

ID=4106144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772725666 Ceased DE2725666A1 (de) 1976-06-07 1977-06-06 Verfahren zur herstellung eines injizierbaren waessrigen kolloids aus technetium-99m-calciumphytat

Country Status (9)

Country Link
JP (1) JPS52151733A (enExample)
BE (1) BE855380A (enExample)
CA (1) CA1053149A (enExample)
CH (1) CH629964A5 (enExample)
DE (1) DE2725666A1 (enExample)
DK (1) DK218877A (enExample)
FR (1) FR2362620A1 (enExample)
GB (1) GB1545024A (enExample)
NL (1) NL7705402A (enExample)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Radioisotopes, 24, 1975, S. 626-632 *

Also Published As

Publication number Publication date
CH629964A5 (en) 1982-05-28
JPS52151733A (en) 1977-12-16
CA1053149A (en) 1979-04-24
JPS624372B2 (enExample) 1987-01-30
DK218877A (da) 1977-12-08
BE855380A (fr) 1977-12-05
FR2362620A1 (fr) 1978-03-24
GB1545024A (en) 1979-05-02
FR2362620B1 (enExample) 1980-04-18
NL7705402A (nl) 1977-12-09

Similar Documents

Publication Publication Date Title
DE2814038C3 (de) Mit einem Radionuklid für radioaktive Tests markierbares Material
DE3129906C2 (enExample)
DE68908175T2 (de) Gefriergetrocknete formulierung für antikörperprodukte.
DE69320481T2 (de) Tetraazamakrocyclische metallkomplexe
DE3640708A1 (de) Verbesserte metallhaltige pharmazeutika
DE2037087B2 (de) Verfahren zur Bestimmung von Schilddrüsenhormongehalt
EP0108253B1 (de) Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung
DE2538388A1 (de) Verfahren zur herstellung eines stabilen, nicht-radioaktiven traegermaterials und seine verwendung zur herstellung von tc-99m-markierten diagnosemitteln
DE2547376A1 (de) Zubereitung fuer die knochenuntersuchung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von knochenskelettbildern
DE2723605C2 (de) Radioaktive Technetiumkomplexe, Verfahren zu deren Herstellung und deren Verwendung zur szintigraphischen Darstellung des hepatobilären Systems
DE2600311A1 (de) Markierte phospholipoidsphaeren fuer die organdarstellung
DE69230970T2 (de) Bicylclische, polyazamakrocyclocarbonsäure-komplexe, konjugate, herstellung und verwendung als kontraststoffe
DE2737932A1 (de) Mittel zur herstellung einer radiodiagnostischen loesung
DE2947500C2 (de) Radiojodierte ω -Phenylfettsäuren, ihre Herstellung und deren Verwendung zur szintigraphischen Untersuchung des Herzmuskels und der Leber
DE2534985C2 (enExample)
DE2234382C3 (de) Verfahren zur in-vitro-Bestimmung einer physiologisch aktiven Substanz in einer Körperflüssigkeit
DE2710728C2 (de) Reagens für die radiologische Abtastung von Organen, Verfahren zu seiner Herstellung und seine Verwendung
DE2639849A1 (de) Verfahren zur herstellung stabiler praeparate wasserloeslicher salze von dehydroepiandrosteronsulfat zur parenteralen verabreichung
DE2725666A1 (de) Verfahren zur herstellung eines injizierbaren waessrigen kolloids aus technetium-99m-calciumphytat
DE2855334A1 (de) Technetium-99m-markiertes (2,4,5-trimethylacetanilido)-iminodiacetat zur leberfunktionsdiagnostik und verfahren zur herstellung
DE3812610A1 (de) Verfahren zur bestimmung der thyroxinbindekapazitaet und dazu geeignete standardloesung
DE2551480B2 (de) Technetium-99m-markiertes Nierendiagnostikum und Verfahren zu seiner Herstellung
DE2327870C2 (de) Verfahren zur Herstellung eines mit 99↑m↑ Tc markierten Phosphat-Zinn-Komplexes zur Szintigraphie
DE2124751A1 (de) Verfahren zur Herstellung eines diagnostischen Präparats auf Basis eines mit 99mTc markierten Eisenkomplexes
AT526035B1 (de) Salinomycin-basierte MRT Kontrastmittel für die Behandlung solider Krebsarten

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection